Bupropion chemical structure
Find information on thousands of medical conditions and prescription drugs.

Zyban

Bupropion (amfebutamone) is an antidepressant of the amino ketone class, chemically unrelated to tricyclics or selective serotonin reuptake inhibitors (SSRIs). It is similar in structure to the stimulant cathinone, and to phenethylamines in general. It is a chemical derivative of diethylpropion, an amphetamine-like substance used as an anorectic. Bupropion is both a dopamine reuptake inhibitor and a norepinephrine reuptake inhibitor. more...

Home
Diseases
Medicines
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Zafirlukast
Zagam
Zalcitabine
Zaleplon
Zanaflex
Zanamivir
Zantac
Zarontin
Zelnorm
Zerit
Zestoretic
Zestril
Zetia
Zevalin
Ziagen
Zidovudine
Zileuton
Ziprasidone
Zithromax
Zocor
Zofran
Zoladex
Zoledronic acid
Zolmitriptan
Zoloft
Zolpidem
Zometa
Zomig
Zonegran
Zonisamide
Zopiclone
Zosyn
Zovia
Zovirax
Zyban
Zymar
Zyprexa
Zyrtec
Zyvox

History

Bupropion was first synthesized by Burroughs Research in 1966, and patented by Burroughs-Wellcome (later Glaxo-Wellcome, and, as of 2000, GlaxoSmithKline) in 1974. It was approved by the FDA in 1985 and marketed under the name Wellbutrin as an antidepressant, but clinical trials indicated that incidence of seizure was two to four times greater than other antidepressants and the drug was quickly pulled from the market. It was subsequently discovered that reducing the dose by about half greatly reduced the risk of seizures. Glaxo then developed a sustained-release (SR) version of Wellbutrin which releases bupropion hydrochloride at a slower rate. The SR formulation is taken twice a day, in order to further decrease the possibility of adverse side effects and seizures. It is also available in generic form (Bupropion SR). Extended Release bupropion, Wellbutrin XL, is the most recent formulation of bupropion and is taken orally once a day. Because of this altered mechanism of delivery and reduced dosing, incidence of seizures with bupropion is comparable to, and in some cases, lower than that of other antidepressants.

In 1997, bupropion HCl was approved by the FDA for use as a smoking cessation aid. Glaxo subsequently marketed the drug under the name Zyban to help people stop smoking tobacco by reducing the severity of craving and addiction/withdrawal symptoms. It can be used in combination with nicotine replacement therapies. Bupropion treatment course lasts for seven to twelve weeks, with the patient halting the use of tobacco around ten days into the course.

Bupropion is also being investigated as a weight loss drug.

Mode of action

Bupropion is a selective catecholamine (norepinephrine and dopamine) reuptake inhibitor. It has only a small effect on serotonin reuptake. It does not inhibit MAO. The actual mechanism behind bupropion's action is not known, but it is thought to be due to the effects on dopaminergic and noradrenergic mechanisms.

Pharmacokinetics

Bupropion is metabolised in the liver. It has at least three active metabolites: hydroxybupropion, threohydrobupropion and erythrohydrobupropion. These active metabolites are further metabolised to inactive metabolites and eliminated through excretion into the urine. The half-life of bupropion is 20 hours as is hydroxybupropion's. Threohydrobupropion's half-life is 37 hours and erythrohydrobupropion's 33 hours.

Chronic hepatotoxicity in animals

In rats receiving large doses of bupropion chronically, there was an increase in incidence of hepatic hyperplastic nodules and hepatocellular hypertrophy. In dogs receiving large doses of bupropion chronically, various histologic changes were seen in the liver, and laboratory tests suggesting mild hepatocellular injury were noted.

Read more at Wikipedia.org


[List your site here Free!]


Salud.(notas breves)(TT: Health.)(TA: brief notes) : An article from: Siempre! $5.95 COPD Patients Fare Best With Zyban for Smoking Cessation.(Brief Article) : An article from: Family Practice News $5.95
Bupropion (Zyban). (Medication Update).(Brief Article) : An article from: Southern Medical Journal $5.95 Einfach nicht mehr rauchen. Zyban - die erste Pille gegen Nikotinsucht. $105.74

Study examines Zyban's use in smoking cessation, weight loss - Brief Article
Study examines Zyban's use in smoking cessation, weight loss.
Does long-term bupropion use prevent smoking relapse after initial success at quitting smoking? - Zyban - Poems
Hays JT, Hurt RD, Rigotti NA, et al. Sustained release bupropion for pharmacologic relapse after smoking cessation. Ann Intern Med 2001; 135:423-33.
COPD Patients Fare Best With Zyban for Smoking Cessation - Brief Article
SAN FRANCISCO -- Smokers with chronic obstructive pulmonary disease are more likely to kick the habit with the help of sustained-release bupropion, Dr. Donald P. Tashkin reported at the annual meet
Antismoking drug comes under scrutiny after deaths - Zyban - News
The manufacturer of the antismoking drug amfebutamone (Zyban), GlaxoSmithKline, has insisted that no evidence exists of an increased risk of death with ...
Glaxo launches TV DTC advertising for Zyban - television direct-to-consumer - Brief Article - Statistical Data Included
Glaxo launched a new direct-to-consumer television ad for Zyban in November, a campaign that emphasized that cigarette smokers struggling to quit may ...
The surprising truth about addiction: more people quit addictions than maintain them, and they do so on their own. That's not to say it happens overnight.
Change is natural. You no doubt act very differently in many areas of your life now compared with how you did when you were a teenager. Likewise, over ...
Rising from the ashes: you've always smoked like a woman. Now you need to quit like one too. The latest research shows that your best shot at tossing tobacco
It was so easy to start smoking. You and your friends took tiny puffs until your lungs could handle a full-out draw. You practiced holding cigarettes ...
Pill eases craving
An experimental drug called varenicline helps smokers kick the habit better than does bupropion, the only drug currently prescribed for the task, a U.S.-Norwegian team of researchers finds. In tw

Home Contact Resources Exchange Links ebay